Iovance Biotherapeutics, Inc. Common Stock

$4.100
USD
Last updated on --.
24h volume15.18M
24h highest4.3880 USD
24h lowest3.8850 USD
24h Price movement+0.00%

IOVA recent prices

24 Hours
+0.00%$0.00
30 days
+20.59%+$0.7
60 days
+19.53%+$0.67
90 days
+9.48%+$0.355

Key data

Previous close4.1000 USD
Market cap1.83B USD
Volume15.18M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.79000 USD
Net income (FY)-353.86M USD
Revenue (FY)285.61M USD
Last report dateMay 7, 2026

About Iovance Biotherapeutics, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersSAN CARLOS
Employees (FY)975.00
Revenue per employee (FY)292.93K USD
Net income per employee (FY)-362.93K USD
Listed onNasdaq
Official website

IOVA conversion tables

IOVAIOVA
USDUSD
0.5 IOVA2.050 USD
1 IOVA4.100 USD
5 IOVA20.5 USD
10 IOVA41 USD
USDUSD
IOVAIOVA
0.5 USD0.12195 IOVA
1 USD0.2439 IOVA
5 USD1.219 IOVA
10 USD2.439 IOVA

FAQ

IOVA is trading at $4.100, +0.00% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IOVA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IOVA is currently trading at $4.100, +0.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IOVA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IOVA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IOVA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IOVA's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Iovance Biotherapeutics, Inc. Common Stock's market cap is currently 1.83B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume15.18M
24h highest4.3880 USD
24h lowest3.8850 USD
24h Price movement+0.00%
IOVAIOVA
USDUSD
Start trade with IOVA Perpetual